Author/Authors :
Licata, Christine School of Medicine - Loma Linda University - Loma Linda, USA , Liu, Lawrence School of Medicine - Loma Linda University - Loma Linda, USA , Mole, Dale Department of Emergency Medicine - Scheer Memorial Adventist Hospital - Banepa, Nepal , Thorp, Jonathon Department of Internal Medicine - Scheer Memorial Adventist Hospital - Banepa, Nepal , Chaulagain, Sabin Department of Internal Medicine - Scheer Memorial Adventist Hospital - Banepa, Nepal , Chand, Rajesh Department of Social Work - Scheer Memorial Adventist Hospital - Banepa, Nepal
Abstract :
Organophosphates are commonly used in rural, agricultural communities worldwide. Poisoning in Nepal is commonly a result ofsuicide attempt via ingestion with a mortality rate of 41 times higher than in the United States even after appropriate treatment. Thepatient discussed in this case is a 46-year-old Nepalese female with a complicated psychosocial history that presented with a suicideattempt via organophosphate ingestion. She required higher doses and greater lengths of treatment of atropine and pralidoximeto resolve symptoms of toxicity that resulted in atropine-induced psychosis, a side effect rarely cited in the literature. This patientwas one of many who attempt suicide in Nepal, where suicide is the leading cause of death for young to middle aged women in thecountry.
